What is DHT?

Dihydrotestosterone (DHT) is a potent androgen hormone derived from testosterone through the action of the enzyme 5-alpha-reductase. While DHT plays important roles in male development, including fetal genital development and secondary sexual characteristics, it is also implicated in the pathogenesis of androgenetic alopecia, commonly known as pattern hair loss.

How DHT Affects Hair Follicles

DHT exerts its effects on hair follicles through binding to androgen receptors:

• Follicle Miniaturization — DHT causes genetically susceptible follicles to progressively shrink over time
• Shortened Growth Phase — The anagen (growth) phase of the hair cycle becomes progressively shorter
• Extended Resting Phase — The telogen (resting) phase extends, leading to increased shedding
• Gradual Transformation — Terminal hairs transform into vellus-like (peach fuzz) hairs

The Hair Follicle Cycle

Understanding the normal hair cycle helps explain how DHT disrupts normal growth:

• Anagen (Growth Phase) — Typically lasts 2-7 years, 85-90% of hairs are in this phase
• Catagen (Transition Phase) — Brief 2-3 week period, 1-2% of hairs
• Telogen (Resting Phase) — 2-4 months, 10-15% of hairs
• Exogen (Shedding Phase) — Old hairs are released as new growth begins

Genetic Susceptibility

Not everyone is equally affected by DHT:

• Follicle Sensitivity — Scalp follicles vary in their sensitivity to DHT
• Androgen Receptor Genes — Genetic variations can affect receptor sensitivity
• 5-Alpha-Reductase Activity — Levels and activity of the enzyme vary between individuals
• Pattern Distribution — Why hair loss follows characteristic patterns (Norwood, Ludwig scales)

DHT and Different Hair Loss Patterns

Male Pattern Baldness (Androgenetic Alopecia)

• Bitemporal recession (receding hairline)
• Vertex thinning (crown area)
• Progressive pattern that may lead to near-complete baldness
• Typically begins in late teens to early 20s

Female Pattern Hair Loss

• Diffuse thinning over the crown
• Preservation of the frontal hairline
• Rarely leads to complete baldness
• Often becomes more apparent after menopause

Treatments Targeting DHT

Finasteride

• Mechanism — Inhibits type II 5-alpha-reductase, reducing DHT production by approximately 70%
• Effectiveness — FDA-approved for male pattern hair loss; clinical studies show stabilization or improvement in most users
• Timeframe — Results typically seen after 3-6 months of consistent use
• Considerations — Requires continued use; not for use by women of childbearing age

Dutasteride

• Mechanism — Inhibits both type I and type II 5-alpha-reductase, reducing DHT by up to 90%
• Status — Used off-label for hair loss in some countries; FDA-approved for benign prostatic hyperplasia
• Effectiveness — Some studies suggest potentially greater efficacy than finasteride
• Considerations — Longer half-life; different side effect profile

Topical Anti-Androgens

• Mechanism — Block androgen receptors locally without systemic effects
• Examples — Topical finasteride, spironolactone preparations (primarily for women)
• Status — Various formulations under investigation; not universally available

Natural Approaches

Some natural compounds may influence DHT or its effects:

• Saw Palmetto — Some studies show mild 5-alpha-reductase inhibition; effects appear weaker than pharmaceutical options
• Pumpkin Seed Oil — Some research suggests modest benefits, though evidence is limited
• Green Tea (EGCG) — May have mild anti-androgenic effects in laboratory studies
• Nettle Root — May inhibit DHT binding to receptors; clinical evidence limited

Understanding Expectations

• DHT inhibition prevents further loss — These treatments are better at preventing new loss than regrowing hair
• Early intervention is more effective — Addressing hair loss early, when follicles are still partially functional, yields better results
• Maintenance is required — Benefits are maintained only with continued treatment
• Individual response varies — Results depend on the degree of follicular miniaturization and individual factors